Characteristics CIN2+ CIN2+ CIN2+ CIN2+ CIN2+ CIN2+ CIN3+ CIN3+ CIN3+
n/N (%) Univariate analysis Univariate analysis Multivariate analysis Multivariate analysis n/N (%) Univariate analysis Univariate analysis
HR (95% CI) P HR (95% CI) P HR (95% CI) P
Age at diagnosis
21-24 years 2/35 (5.7%) 0.686 (0.162-2.910) 0.609 1/35 (2.9%) 0.893 (0.113-7.050) 0.914
≥25 years 23/314 (7.3%) Reference 9/314 (2.9%) Reference
Marital status
Married 21/274 (7.7%) Reference 8/274 (2.9%) Reference
Single 4/75 (5.3%) 0.449 (0.765-6.497) 0.142 2/75 (2.7%) 0.343 (0.618-13.720) 0.177
Childbearing
≥1 20/273 (7.3%) 1.096 (0.411-2.920) 0.855 8/273 (2.9%) 1.087 (0.231-5.122) 0.916
0 5/76 (6.6%) Reference 2/76 (2.6%) Reference
Contraception
Oral contraceptive 6/50 (12.0%) 2.364 (0.931-6.007) 0.0705 2/49 (4.1%) 1.332 (0.269-6.602) 0.726
Condom 5/90 (5.6%) 0.785 (0.478-3.965) 0.629 2/90 (2.2%) 0.824 (0.166-4.086) 0.813
Other 14/209 (6.7%) Reference 6/210 (2.9%) Reference
Menopausal status
Premenopause 20/296 (6.8%) Reference 8/296 (2.7%) Reference
Menopause 5/53 (9.4%) 1.954 (0.779-4.902) 0.153 2/53 (3.8%) 1.490 (0.316-7.029) 0.614
Sexual debut
<20 years old 6/57 (10.5%) 1.809 (0.722-4.535) 0.206 3/57 (5.3%) 2.431 (0.627-9.421) 0.199
≥20 years old 19/292 (6.5%) Reference 7/292 (2.4%) Reference
Sexual partner
≥2 8/65 (12.3%) 2.491 (1.073-5.784) 0.034 1.982 (0.843-4.663) 0.117 4/65 (6.2%) 3.389 (0.954-12.040) 0.059
1 17/284 (6.0%) Reference 6/284 (2.1%) Reference
Enrollment cytology
ASC-US/LSIL 15/136 (11.0%) 2.339 (1.051-5.207) 0.037 2.081 (0.932-4.650) 0.074 5/136 (3.7%) 1.552 (0.449-5.363) 0.487
NILM 10/213 (4.7%) Reference 5/213 (2.3%) Reference
AHPV genotyping
AHPV-GT+ 11/58 (19.0%) 4.155 (1.885-9.160) <0.001 3.462 (1.546-7.749) 0.003 5/58 (8.6%) 5.153 (1.490-17.820) 0.010
AHPV-GT– 14/291 (4.8%) Reference 5/291 (1.7%) Reference